{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:31:57Z","timestamp":1760851917378},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1016\/s0304-3835(99)00441-3","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T02:20:59Z","timestamp":1027650059000},"page":"135-143","source":"Crossref","is-referenced-by-count":22,"title":["Limited synergistic effect of antisense oligonucleotides against bcr-abl and transferrin receptor mRNA in leukemic cells in culture"],"prefix":"10.1016","volume":"152","author":[{"given":"M.Helena","family":"Vasconcelos","sequence":"first","affiliation":[]},{"given":"Sandra S.","family":"Beleza","sequence":"additional","affiliation":[]},{"given":"Catriona","family":"Quirk","sequence":"additional","affiliation":[]},{"given":"Lu\u0131\u0301s F.","family":"Maia","sequence":"additional","affiliation":[]},{"given":"Clara","family":"Sambade","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 E.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0304-3835(99)00441-3_BIB1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1126\/science.1857987","article-title":"Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides","volume":"253","author":"Szczylik","year":"1991","journal-title":"Science"},{"key":"10.1016\/S0304-3835(99)00441-3_BIB2","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1073\/pnas.91.10.4504","article-title":"Suppression of Philadelphia leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide","volume":"91","author":"Skorski","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/S0304-3835(99)00441-3_BIB3","first-page":"129","article-title":"Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173","volume":"8","author":"Smetsers","year":"1994","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/S0304-3835(99)00441-3_BIB4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V83.5.1179.1179","article-title":"BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death","volume":"83","author":"McGahon","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0304-3835(99)00441-3_BIB5","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1073\/pnas.86.9.3379","article-title":"An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines","volume":"86","author":"Anfossi","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0304-3835(99)00441-3_BIB6","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1073\/pnas.88.6.2351","article-title":"Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging","volume":"88","author":"Calabretta","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0304-3835(99)00441-3_BIB7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/328445a0","article-title":"c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1","volume":"328","author":"Heikkila","year":"1987","journal-title":"Nature"},{"issue":"4","key":"10.1016\/S0304-3835(99)00441-3_BIB8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/nar\/19.4.945","article-title":"Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene","volume":"19","author":"Degols","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/S0304-3835(99)00441-3_BIB9","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1073\/pnas.94.8.3966","article-title":"Antileukemia effect of c-myc N3\u2032-P5\u2032 phosphoramidate antisense oligonucleotides in vivo","volume":"94","author":"Skorski","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/S0304-3835(99)00441-3_BIB10","first-page":"510a","article-title":"Inhibition of Bcl-2 with liposomal P-ethoxy antisense oligonucleotides induces apoptosis in the presence of high level of Bcl-XL and is critically depending on baseline Bcl-2 levels in AML","volume":"92","author":"Konopleva","year":"1998","journal-title":"Blood"},{"issue":"10","key":"10.1016\/S0304-3835(99)00441-3_BIB11","first-page":"187b","article-title":"The effect of Bcl-2 antisense oligonucleotides on B-CLL in vitro survival","volume":"92","author":"Pepper","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S0304-3835(99)00441-3_BIB12","series-title":"Molecular Aspects of Cancer and its Therapy","first-page":"151","article-title":"Antisense strategy for cancer therapy","author":"Skorski","year":"1998"},{"issue":"Suppl. 1","key":"10.1016\/S0304-3835(99)00441-3_BIB13","first-page":"514a","article-title":"Human Leukemia treatment in SCID mice by antisense oligodeoxynucleotides targeting cooperating oncogenes","volume":"84","author":"Skorski","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0304-3835(99)00441-3_BIB14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.182.6.1645","article-title":"Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes","volume":"182","author":"Skorski","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0304-3835(99)00441-3_BIB15","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1182\/blood.V88.3.1005.1005","article-title":"Antisense oligodeoxynucleotide combination treatment of primary chronic myelogenous leukemia blast crisis in SCID mice","volume":"88","author":"Skorski","year":"1996","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/S0304-3835(99)00441-3_BIB16","first-page":"607a","article-title":"An antisense oligonucleotide to the transferrin receptor inhibits proliferation of leukemic cells in vitro","volume":"84","author":"Guimaraes","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0304-3835(99)00441-3_BIB17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/S0304-3835(99)00441-3_BIB18","first-page":"118","article-title":"Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular Bcr-Abl protein levels","volume":"9","author":"Smetsers","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/S0304-3835(99)00441-3_BIB19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0168-3659(92)90115-8","article-title":"Liposome delivery of antisense oligonucleotides: adsorption and efflux characteristics of phosphorothioate oligodeoxynucleotides","volume":"22","author":"Akhtar","year":"1992","journal-title":"J. Control Rel."},{"issue":"3","key":"10.1016\/S0304-3835(99)00441-3_BIB20","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1182\/blood.V91.3.852","article-title":"Oligodeoxyribonucleotide uptake in primary human hematopoietic cells is enhanced by cationic lipids and depends on the hematopoietic cell subset","volume":"91","author":"Kronenwett","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S0304-3835(99)00441-3_BIB21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/ard.1995.5.13","article-title":"Nuclear delivery of antisense oligodeoxynucleotides through reversible permeabilization of human leukemia cells with Streptolysin O","volume":"5","author":"Spiller","year":"1995","journal-title":"Antisense Res. Dev."},{"key":"10.1016\/S0304-3835(99)00441-3_BIB22","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/sj.leu.2400774","article-title":"Preclinical studies of streptolysin-O in enhancing antisense oligonucleotide uptake in harvests from chronic myeloid leukaemia patients","volume":"11","author":"Broughton","year":"1997","journal-title":"Leukemia"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383599004413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383599004413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T02:32:41Z","timestamp":1580869961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383599004413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["S0304383599004413"],"URL":"https:\/\/doi.org\/10.1016\/s0304-3835(99)00441-3","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}